Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NeoGenomics, Inc. - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NEO
Nasdaq
8081
www.neogenomics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NeoGenomics, Inc.
NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology
- Oct 15th, 2026 5:05 am
NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026
- Oct 14th, 2026 5:05 am
3 Small-Cap Stocks with Questionable Fundamentals
- Oct 13th, 2026 5:07 am
Why NeoGenomics (NEO) Stock Is Up Today
- Oct 6th, 2026 2:32 pm
Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive
- Oct 6th, 2026 2:31 pm
NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue Beat
- Oct 6th, 2026 11:09 am
Did Strong Q3 Outlook and New CEO Plan Just Shift NeoGenomics' (NEO) Investment Narrative?
- Oct 6th, 2026 11:08 am
NeoGenomics stock falls on CEO transition announcement
- Oct 5th, 2026 3:34 pm
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
- Oct 5th, 2026 2:05 pm
Why Women-Run Companies Deserve a Place in Your Portfolio
- Sep 24th, 2026 10:42 am
3 Healthcare Stocks We’re Skeptical Of
- Sep 23rd, 2026 4:37 am
3 Reasons NEO is Risky and 1 Stock to Buy Instead
- Sep 22nd, 2026 10:21 am
NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued?
- Sep 22nd, 2026 2:20 am
Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine?
- Sep 21st, 2026 7:13 am
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
- Sep 20th, 2026 8:02 pm
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
- Sep 18th, 2026 6:40 am
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
- Sep 18th, 2026 1:45 am
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
- Sep 11th, 2026 6:11 am
3 Promising Genomics Stocks in the Spotlight in 2026
- Sep 8th, 2026 10:46 am
Anortech Receives US$1.0 Million Cash and Shares from Sarfartoq Ree Project Transaction
- Sep 3rd, 2026 7:00 am
Scroll